Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumab

ConclusionsOur data continue to support an increased risk of infections with Gram-positive cocci as a potentially serious adverse event in women treated with pertuzumab and trastuzumab.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research